Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PRQR stock hub

ProQR Therapeutics N.V. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PRQRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

166.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PRQR

In the news

Latest news · PRQR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-61.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-31.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PRQR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

EUR

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001612940
Company name	ProQR Therapeutics N.V.
Country	Netherlands
Country code	US
Cusip	N71542109
Employees	186.6
Employees Change	20.5%
Employees Change Percent	12.34
Enterprise value	$76.7M
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2014-09-18
Isin	NL0010872495
Last refreshed	2026-05-10
Market cap	$166.5M
Market cap category	Micro-Cap
Price	$1.58
Price currency	USD
Rev Per Employee	102,858.4x
Sector	Healthcare
Sic	2834
Symbol	PRQR
Website	https://www.proqr.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-29.75%
EV Sales Forward	4.43x
EV/Sales	4x
FCF yield	-38.12%
P/B ratio	2.87x
P/S ratio	8.67x
PS Forward	9.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-265.77%
EBITDA Margin	-260.26%
Gross margin	100%
Gross Profit	$19.2M
Gross Profit Growth	-16.36%
Gross Profit Growth Q	6.14%
Gross Profit Growth3 Y	55.36%
Gross Profit Growth5 Y	73.86%
Net Income	$-49.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-257.94%
Profit Margin	-258.05%
Profit Per Employee	$-265,430
ROA	-19.35
Roa5y	-18.09
ROCE	-54.09
ROE	-61.17
Roe5y	-59.64
ROIC	-31.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-10.46%
Cagr1y	0.64%
Cagr3y	-9.19%
Cagr5y	-24%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-16.36x
Revenue Growth Q	6.14x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	55.36x
Revenue Growth5 Y	73.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.12
Assets	$132.4M
Cash	$108.5M
Current Assets	$118.1M
Current Liabilities	$38.3M
Debt	$18.7M
Debt Equity	$0.32
Equity	$58M
Interest Coverage	-46.77
Liabilities	$74.4M
Long Term Assets	$14.3M
Long Term Liabilities	$36.2M
Net Cash	$89.8M
Net Cash By Market Cap	$53.92
Net Cash Growth	-42.17%
Net Debt Equity	$-1.55
Tangible Book Value	$58M
Tangible Book Value Per Share	$0.55
WACC	4.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.09
Net Working Capital	$-21.5M
Quick ratio	3.01
Working Capital	$79.5M
Working Capital Turnover	$0.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.36%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-66.88%
1Y total return	0.64%
200-day SMA	2
3Y total return	-25.12%
50-day SMA	1.69
50-day SMA vs 200-day SMA	50under200
5Y total return	-74.64%
All Time High	27.6
All Time High Change	-94.28%
All Time High Date	2015-03-16
All Time Low	0.53
All Time Low Change	198.11%
All Time Low Date	2022-05-11
ATR	0.14
Beta	0.07
Beta1y	2
Beta2y	2.07
Ch YTD	-21.78
High	1.63
High52	3.1
High52 Date	2025-10-21
High52ch	-49.03%
Low	1.51
Low52	1.33
Low52 Date	2026-02-12
Low52ch	18.8%
Ma50ch	-6.45%
Premarket Change Percent	3.11
Premarket Price	$1.63
Premarket Volume	5,538
Price vs 200-day SMA	-20.96%
RSI	45.3
RSI Monthly	44.19
RSI Weekly	44.86
Sharpe ratio	0.3x
Sortino ratio	0.52
Total Return	-22.36%
Tr YTD	-21.78
Tr1m	-7.06%
Tr1w	1.94%
Tr3m	5.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	3
Analyst Price Target Top	$7
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.15
Earnings Revenue Estimate	5,530,000x
Earnings Revenue Estimate Growth	16.37x
Operating Income	$-51M
Operating margin	-265.8
Price target	$7.25
Price Target Change	$359
Price Target Change Top	$343

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	64,346,330%
Float Percent	61.07%
Net Borrowing	-2,246,562.9
Shares Insiders	2.03%
Shares Institutions	30.01%
Shares Out	105,361,064
Shares Qo Q	0.01%
Shares Yo Y	22.36%
Short Ratio	2.19
Short Shares	1.77

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-68.2M
Average Volume	742,565.1x
Bv Per Share	0.55
CAPEX	$-1.2M
Ch10y	-66.88
Ch1m	-7.06
Ch1w	1.94
Ch1y	0.64
Ch3m	5.33
Ch3y	-25.12
Ch5y	-74.64
Ch6m	-28.83
Change	0%
Change From Open	0.64
Close	1.58
Days Gap	-0.63
Depreciation Amortization	1,063,726.9
Dollar Volume	1,049,060
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-51M
EBITDA	$-50M
EPS	$-0.47
F Score	0
FCF	$-63.5M
FCF EV Yield	-82.73x
FCF Per Share	$-0.6
Financing CF	-2,155,689
Fiscal Year End	December
Founded	2,012
Income Tax	$22,308
Investing CF	-1,197,605
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	1.95
Ma150ch	-18.77%
Ma20	1.7
Ma20ch	-7.06%
Net CF	-66,919,103
Next Earnings Date	2026-05-22
Open	1.57
Optionable	Yes
Position In Range	58.33
Post Close	1.58
Postmarket Change Percent	5.09
Postmarket Price	$1.66
Ppne	14,894,535.4
Pre Close	1.58
Price Date	2026-05-08
Ptbv Ratio	2.87
Relative Volume	0.89x
Revenue	19,193,378x
SBC By Revenue	24.55x
Share Based Comp	4,712,927
Tax By Revenue	0.12x
Tr6m	-28.83%
Volume	663,962
Z Score	-4.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PRQR pay a dividend?

Capital-return profile for this ticker.

Performance

PRQR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PRQR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+30.0%

Float: +61.1% of shares outstanding

Insider ownership

+2.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PRQR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.3

Neutral momentum band

Price vs 200-day MA

-21.0%

50/200-day relationship not available

Beta (5Y)

0.07

Less volatile than the market

Sharpe ratio

0.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PRQR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PRQR stock rating?

ProQR Therapeutics N.V. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PRQR analysis?

The full report lives at /stocks/PRQR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PRQR?

The latest report frames PRQR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PRQR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.